MedPath

AI Health Assistant and Type 2 Diabetes

Not Applicable
Not yet recruiting
Conditions
Health Behavior
Type2 Diabetes Mellitus
Registration Number
NCT05539066
Lead Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Brief Summary

The developed health assistant has the functions of intelligent analysis of health data inside and outside the hospital, health reminder, etc. The advantages of AI health assistant management group compared with conventional management group in terms of comprehensive compliance rate, metabolic index level, hypoglycemia incidence rate was further studied.

Detailed Description

1. The investigators have developed an AI health assistant suitable for diabetes patients, which has the functions of automatically uploading blood pressure, blood glucose data, intelligent reminder, automatic analysis of reports inside and outside the hospital, intelligent question and answer, etc. it is simple to operate, highly interactive, and maximizes the management level of diabetes patients outside the hospital.

2. Through AI personal health assistant, 196 diabetes patients were managed to further improving the comprehensive compliance rate of metabolic indicators such as blood glucose and blood pressure of diabetes patients, improving the patients' self-management ability.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
196
Inclusion Criteria

The diagnostic criteria of T2DM patients are the diagnostic criteria of the 2017 China guidelines for the prevention and treatment of type 2 diabetes HbA1c 7.5-13% Age: 18-65y BMI 18.5-30kg/m2 The course of disease is less than 5 years Have good cognitive ability and can correctly use health assistants

Exclusion Criteria

Acute complications of diabetes (diabetes ketosis, etc.) Diabetes complicating pregnancy or preparing for pregnancy HbA1c < 7.5% or > 13% Age < 18y or age > 65y Pre pregnancy BMI < 18.5 or > 30kg / m2 Severe liver and kidney dysfunction (ALT greater than 2.5 times the upper limit of normal, EGFR less than 45 ml / min / 1.73m2) Using drugs that may affect blood glucose are being used (including steroids, hydroxyprogesterone hexanoate, anti AIDS drugs, etc.)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Blood pressure compliance rate6 months

Proportion of patients with blood pressure \< 130 / 80mmHg

Compliance rate of total cholesterol6 months

Proportion of patients with total cholesterol \< 4.5mmol/l

Compliance rate of BMI (Body Mass Index)6 months

Proportion of patients with BMI \< 24 kg/m2

HbA1c compliance rate6 months

Compliance rate of HbA1c \< 7%

Secondary Outcome Measures
NameTimeMethod
Incidence of hypoglycemia6 months

Number of attacks with blood glucose less than 3.8mmol/l

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.